Moreover, RBBP4 KD sensitized AML cells to FK228 treatment (Fig. 7h and Supplementary Fig. 7h), consistent with our findings that RNF5 positively regulates RBBP4. This evidence concerns the gene RNF5 and acute myeloid leukemia.